http://www.medpagetoday.com/Cardiology/Strokes/50109?xid=nl_mpt_DHE_2015-02-20&
Worse Than No Study At All
02/20/15
We need valid studies with control groups, and the influence of possible
mitigating factors, to identify whether their really is an association with stroke,
instead of these worthless attempts to inject personal prejudices into a
complicated discussion. The article did not even make the first distinction
necessary to discuss stroke, i. e. hemorrhagic vs atherosclerotic strokes, which
have completely different etiologies. For example, if we know the risk rises due
to sclerotic disease, can we mitigate those patients through the standard ASA /
statin / beta blocker combo that we use for heart disease? 50 or 60 case histories
of stroke, people who just happen to use cannabis, tells us nothing. Weed is here
to stay. It's time to grow up and try to help this significant population through
pragmatic study and harm reduction if possible. [Ed.: All the cases involved ischemic stroke.].
larry katz
02/20/15
This type of medical incompetence is applied to Cannabis research over and over
again. The lack of proper research protocols is clearly an example of the intentional
injection of bogus information meant to cloud the public's perception of the
potential value of the drug. A little real research will undoubtedly prove this scare
tactic is borne of a connection to big pharma that has little use for pot as a profit
source. This "researcher" should be ashamed to publish such garbage on the level
of "Reefer Madness".
Steve Edelman, MSN/FNP-BC
02/20/15
If this was another
drug being
"investigated" we
would laugh at this
researcher and, from
that point on we
would ignore him.
Still sounds like a
good plan to me!.